Significant biosimilar activities this week include:

  • On 09 March 2020, the FDA and FTC held a public workshop to further their efforts in creating a better biosimilar landscape in the US. The Centre for Biosimilars reported that topics discussed at the conference in...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags